The XIII Eurasian Hematology-Oncology Congress (EHOC) was held on 5-8 October 2022 in Istanbul, Turkey, and saw hemonc experts gather to discuss the latest updates in adult and pediatric hematology and nursing.
View all videos

EHOC 2022

The 13th Eurasian Hematology-Oncology Congress
05–08 October 2022 | Istanbul, Turkey

Claudio Cerchione (@DottorClaudio) discusses the importance of gene expression profiling and molecular testing in multiple myeloma:

👉http://ow.ly/WnjW50LM94U👈

@sohoitaly #SOHOItaly2022 #MMsm #HemOnc

The CONCEPT trial is a good proof of concept on how to improve the outcome of high risk myeloma #ASH22 ⁦@COMyCongress⁩ ⁦@TheIACH⁩ ⁦@Mohty_EBMT⁩

We're hosting a Post-ASH Virtual Workshop Series, featuring presentations & discussions on selected abstracts from the 64th #ASH22 Annual Meeting💻🩸

Register for the #ALL session with Elias Jabbour, Sabina Chiaretti, Daniel DeAngelo & @LuskinMarlise👉 http://bit.ly/3XI9HVN

NEW VJSocial Masterclass coming this week all about Social Media Strategy📱

@doctorpemm, @mpdrc & @harrisoncn1 share their own tips & advice on building a social media strategy alongside your clinical practice💡

Check out our previous Masterclass here: http://bit.ly/3UfLxiq

#ESHCML2022 | Toshio Kitamura comments on the impact of BCR-ABL mutations on signaling pathway activation in patients with CML.

Watch his interview here:

🎥: http://ow.ly/aiRv50LM8Rq

@ESHaematology #LeuSM #HemOnc #CMLsm

Load More...

EHOC 2022

The 13th Eurasian Hematology-Oncology Congress
05–08 October 2022 | Istanbul, Turkey
The XIII Eurasian Hematology-Oncology Congress (EHOC) was held on 5-8 October 2022 in Istanbul, Turkey, and saw hemonc experts gather to discuss the latest updates in adult and pediatric hematology and nursing.
View all videos

Claudio Cerchione (@DottorClaudio) discusses the importance of gene expression profiling and molecular testing in multiple myeloma:

👉http://ow.ly/WnjW50LM94U👈

@sohoitaly #SOHOItaly2022 #MMsm #HemOnc

The CONCEPT trial is a good proof of concept on how to improve the outcome of high risk myeloma #ASH22 ⁦@COMyCongress⁩ ⁦@TheIACH⁩ ⁦@Mohty_EBMT⁩

We're hosting a Post-ASH Virtual Workshop Series, featuring presentations & discussions on selected abstracts from the 64th #ASH22 Annual Meeting💻🩸

Register for the #ALL session with Elias Jabbour, Sabina Chiaretti, Daniel DeAngelo & @LuskinMarlise👉 http://bit.ly/3XI9HVN

NEW VJSocial Masterclass coming this week all about Social Media Strategy📱

@doctorpemm, @mpdrc & @harrisoncn1 share their own tips & advice on building a social media strategy alongside your clinical practice💡

Check out our previous Masterclass here: http://bit.ly/3UfLxiq

#ESHCML2022 | Toshio Kitamura comments on the impact of BCR-ABL mutations on signaling pathway activation in patients with CML.

Watch his interview here:

🎥: http://ow.ly/aiRv50LM8Rq

@ESHaematology #LeuSM #HemOnc #CMLsm

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter